This project will confirm if Ultra TB testing performs well in PLHIV irrespective of symptoms, and may produce evidence that supports universal TB testing in this important and vulnerable patient group. The investigators will also assess whether POC placement of Ultra and Xpert VL has benefits (e.g., more patients diagnosed for TB or VL monitored during the same day visit).